In a 2015 report, researchers described using externally generated micro-shock waves to trigger drug release from tiny polymer capsules. The experiments included insulin delivery under the skin and ciprofloxacin treatment of a superficial infection in diabetic mice. They did not establish a treatment for people: the work was experimental, and the report noted that the shock-wave generator used a small controlled explosion.
How shock waves trigger drug release
The researchers made microcapsules from spermidine and dextran sulphate, polymers the report described as biocompatible. The capsules remained stable at physiological pH and temperature. When exposed to shock waves, increased pressure prompted them to release their loaded drug slowly.
As an Amazon Associate I earn from qualifying purchases.
The capsules could be placed under the skin or used at topical sites. An external device generated the shock waves; in the report, that device relied on a small controlled explosion. The team was working to eliminate explosives from the generator.
Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchPC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11What the experiments tested
Insulin release beneath the skin
The team cited the need to reduce repeated insulin injections as one motivation for the approach. In the reported experiment, insulin-loaded capsules were injected under the skin and drug release was triggered externally. This was a research demonstration, not a human trial or an established alternative to insulin treatment.
#1 Best Overall
Ciprofloxacin for a superficial infection in mice
In a separate experiment, the researchers used shock waves to release ciprofloxacin from capsules in diabetic mice with a superficial Staphylococcus aureus skin infection. The report says the treatment rescued the mice, while the same result was not observed without micro-shock exposure.
The report suggested that biofilm disruption, wound healing, and angiogenesis might have contributed. It did not establish those mechanisms or show a clinical benefit in people.
Rank #2
- Used Book in Good Condition
What the evidence does—and does not—show
The results described proof of concept for externally triggered delivery at surface and near-surface sites. They do not show that the method can deliver drugs effectively to diseased tissue deep inside the body. Cameron Alexander, a drug-delivery expert at the University of Nottingham, told Chemistry World: “The data is interesting, and this may be a promising new method for triggered drug delivery at surface and near-surface sites, but further work will be needed to demonstrate efficacy in diseased tissue inside the body,”
The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →The report, published on 2 February 2015, does not establish whether the system later reached human trials, received regulatory approval, or became commercially available. It should not be read as evidence of current clinical readiness.
Rank #3
The study behind the report
Chemistry World’s account concerns research by Dipshikha Chakravortty and colleagues at the Indian Institute of Science in Bangalore. It identifies the underlying paper as D. P. Gnanadhas et al., RSC Advances 5 (2015), 13234, DOI 10.1039/c4ra15270k. The report is a secondary account; its description alone does not provide the primary study’s full methods or establish later development.
Quick Recap
Rank #4
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
